Barbara Kind

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Improvement of Depressive and Fatigue Symptoms under Dupilumab Therapy in Atopic Dermatitis Patients: Results from the TREATgermany Registry.

Improvement of Depressive and Fatigue Symptoms under Dupilumab Therapy in Atopic Dermatitis Patients: Results from the TREATgermany Registry.

Journal: Acta dermato-venereologica

Published: April 16, 2026

Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.

Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.

Journal: Acta dermato-venereologica

Published: March 26, 2026

Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: An analysis from the TREATKids registry.

Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: An analysis from the TREATKids registry.

Journal: The Journal of investigative dermatology

Published: March 26, 2026

Patient treatment needs in atopic dermatitis: A real-world cohort study.

Patient treatment needs in atopic dermatitis: A real-world cohort study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 15, 2026

PSCA-directed nanosized bio-immune conjugates (NANO:BICs) enable selective uptake of TLR9 agonists in bladder cancer cells.

PSCA-directed nanosized bio-immune conjugates (NANO:BICs) enable selective uptake of TLR9 agonists in bladder cancer cells.

Journal: Frontiers in oncology

Published: November 04, 2025

Keratinocyte Priming by Staphylococcus aureus Reduces HSV-1 Susceptibility.

Keratinocyte Priming by Staphylococcus aureus Reduces HSV-1 Susceptibility.

Journal: Allergy

Published: October 07, 2025

Anthropometric patterns in children with moderate-to-severe atopic dermatitis: Cross-sectional insights from the TREATkids cohort.

Anthropometric patterns in children with moderate-to-severe atopic dermatitis: Cross-sectional insights from the TREATkids cohort.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: September 15, 2025

Type I-interferon β induces a strong anti-tumour response in bladder cancer cells.

Type I-interferon β induces a strong anti-tumour response in bladder cancer cells.

Journal: Journal of cancer research and clinical oncology

Published: August 20, 2025

Real-world effectiveness and safety of tralokinumab therapy in moderate-to-severe atopic dermatitis: insights from the TREATgermany registry.

Real-world effectiveness and safety of tralokinumab therapy in moderate-to-severe atopic dermatitis: insights from the TREATgermany registry.

Journal: Clinical and experimental dermatology

Published: July 15, 2025

Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry.

Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry.

Journal: Acta dermato-venereologica

Published: October 21, 2024

The importance of registries in clinical practice: Insights from the national atopic dermatitis registry TREATgermany.

The importance of registries in clinical practice: Insights from the national atopic dermatitis registry TREATgermany.

Journal: Allergologie select

Published: October 15, 2024

Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry.

Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry.

Journal: Allergy

Published: February 07, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026